Microwave thermal ablation (MTA) is an increasingly relevant cancer treatment targetting focal malignancies, in which high temperatures are induced into the target zone by way of the absorption of electromagnetic energy at microwave (MW) frequencies (typically 915 MHz or 2.45 GHz). Thermal ablation is achieved almost instantaneously when temperatures of 55-60 °C or higher are reached in the zone of treatment, which should encompass the tumour lesion plus a 5-10 mm safety margin of surrounding healthy tissue (Goldberg et al 2000, Ryan et al 2010.The main advantages of MTA, with respect to conventional surgery, are related to the limited invasiveness and cost of the treatment, which allow reducing recovery times, complication rates and hospital stays. Moreover, MTA is gaining increasing interest in clinical practice, due to its capability of treating large tissue volumes (up
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.